NO20004274D0 - Protease-activated receptor 4 and its use - Google Patents
Protease-activated receptor 4 and its useInfo
- Publication number
- NO20004274D0 NO20004274D0 NO20004274A NO20004274A NO20004274D0 NO 20004274 D0 NO20004274 D0 NO 20004274D0 NO 20004274 A NO20004274 A NO 20004274A NO 20004274 A NO20004274 A NO 20004274A NO 20004274 D0 NO20004274 D0 NO 20004274D0
- Authority
- NO
- Norway
- Prior art keywords
- protease
- activated receptor
- receptor
- activated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3239798A | 1998-02-27 | 1998-02-27 | |
PCT/US1999/002983 WO1999043809A2 (en) | 1998-02-27 | 1999-02-11 | Protease-activated receptor 4 and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20004274D0 true NO20004274D0 (en) | 2000-08-25 |
NO20004274L NO20004274L (en) | 2000-10-13 |
Family
ID=21864751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20004274A NO20004274L (en) | 1998-02-27 | 2000-08-25 | Protease-activated receptor 4 and its use |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1056854A2 (en) |
JP (1) | JP2002504369A (en) |
KR (1) | KR20010041418A (en) |
AU (1) | AU2672899A (en) |
CA (1) | CA2321142A1 (en) |
NO (1) | NO20004274L (en) |
WO (1) | WO1999043809A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5892014A (en) | 1996-10-30 | 1999-04-06 | The Regents Of The University Of California | DNA encoding a protease-activated receptor 3 |
US6111075A (en) * | 1998-04-01 | 2000-08-29 | Zymogenetics, Inc. | Protese-activated receptor PAR4 (ZCHEMR2) |
US7256172B1 (en) * | 1998-09-15 | 2007-08-14 | The University Of Melbourne | Method of treatment and agents useful for same |
US7026155B2 (en) | 1999-02-02 | 2006-04-11 | Regents Of The University Of California | Method of reducing bacterial proliferation |
GB9925005D0 (en) | 1999-10-22 | 1999-12-22 | Univ Nottingham | The treatment of wounds |
CA2399566A1 (en) * | 2000-02-09 | 2001-08-16 | Zymogenetics, Inc. | Par4 peptides and polypeptides |
AU2001238366A1 (en) * | 2000-02-17 | 2001-08-27 | The Regents Of The University Of California | Methods of modulating protease-activated receptor-4 (par4) activation via cathepsin |
WO2001094411A1 (en) * | 2000-06-05 | 2001-12-13 | The Regents Of The University Of California | Peptides modulating protease activated receptors and methods of using same |
US6841354B2 (en) * | 2000-12-21 | 2005-01-11 | Philadelphia, Health & Education Corporation | Screening assay for anti-thrombotic/anti-platelet activity |
US7179887B2 (en) | 2001-03-02 | 2007-02-20 | Ortho-Mcneil Pharmaceutical, Inc. | Guinea pig proteinase-activated receptor 4 and its activating peptide |
WO2004080372A2 (en) * | 2003-03-11 | 2004-09-23 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 4 (par4) |
US20070243632A1 (en) | 2003-07-08 | 2007-10-18 | Coller Barry S | Methods for measuring platelet reactivity of patients that have received drug eluting stents |
EP1641492B1 (en) | 2003-07-08 | 2011-12-14 | Accumetrics, Inc. | Controlled platelet activation to monitor therapy of adp antagonists |
US20080299587A1 (en) * | 2007-05-03 | 2008-12-04 | Dennis Durbin | Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists |
GB2450747A (en) * | 2007-07-06 | 2009-01-07 | Univ Sheffield | Treatment of sensorineural hearing loss |
JP5257997B2 (en) | 2008-01-31 | 2013-08-07 | 国立大学法人大阪大学 | Tag peptide and use thereof |
EP3054936B1 (en) | 2013-10-10 | 2023-10-18 | Eastern Virginia Medical School | 4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivatives as 12-lipoxygenase inhibitors |
WO2017011550A1 (en) | 2015-07-13 | 2017-01-19 | University Of Utah Research Foundation | Methods of making red blood cells and platelets in vitro and uses thereof |
CA3075523A1 (en) | 2017-09-11 | 2019-03-14 | Monash University | Binding proteins to the human thrombin receptor, par4 |
CA3115104A1 (en) * | 2018-10-05 | 2020-04-09 | University Of Utah Research Foundation | Methods of making platelets comprising modified receptors and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5686597A (en) * | 1995-06-06 | 1997-11-11 | Incyte Pharmaceuticals, Inc. | Thrombin receptor homolog |
US5892014A (en) * | 1996-10-30 | 1999-04-06 | The Regents Of The University Of California | DNA encoding a protease-activated receptor 3 |
WO1998031810A2 (en) * | 1997-01-21 | 1998-07-23 | Schering Corporation | Mammalian chemokines; receptors; reagents; uses |
-
1999
- 1999-02-11 EP EP99906934A patent/EP1056854A2/en not_active Withdrawn
- 1999-02-11 CA CA002321142A patent/CA2321142A1/en not_active Abandoned
- 1999-02-11 AU AU26728/99A patent/AU2672899A/en not_active Abandoned
- 1999-02-11 WO PCT/US1999/002983 patent/WO1999043809A2/en not_active Application Discontinuation
- 1999-02-11 JP JP2000533549A patent/JP2002504369A/en not_active Withdrawn
- 1999-02-11 KR KR1020007009552A patent/KR20010041418A/en not_active Application Discontinuation
-
2000
- 2000-08-25 NO NO20004274A patent/NO20004274L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20010041418A (en) | 2001-05-15 |
WO1999043809A3 (en) | 1999-10-14 |
EP1056854A2 (en) | 2000-12-06 |
CA2321142A1 (en) | 1999-09-02 |
NO20004274L (en) | 2000-10-13 |
AU2672899A (en) | 1999-09-15 |
WO1999043809A2 (en) | 1999-09-02 |
JP2002504369A (en) | 2002-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20032753D0 (en) | Compound and Use thereof | |
NL300295I1 (en) | 3,3-Diarylpropylamines, their use and preparation | |
IS4481A (en) | Dihydropyramidine and their use | |
DK1454907T3 (en) | Quninazoline and pyridopyrmidine derivatives | |
NO20004274D0 (en) | Protease-activated receptor 4 and its use | |
IS6411A (en) | Kaspasa inhibits and their use | |
DK0915880T3 (en) | Azolotriazines and pyrimidines | |
DE69734443D1 (en) | OB RECEPTOR AND LIGANDS | |
DK1003774T3 (en) | GnRH antagonists modified at positions 5 and 6 | |
NO984354D0 (en) | Newspaper and its use | |
DE69832657D1 (en) | Receiving devices and receiving methods | |
DE69835254D1 (en) | Receiving devices and receiving methods | |
DK0804078T3 (en) | Composition and use thereof | |
NO20006488D0 (en) | Composition and application | |
DE69714725D1 (en) | PERSONAL ORIENTATION DEVICE | |
PT9373T (en) | ANATOMICAL PILLOW AND PILLOW | |
IS5942A (en) | 3,3-barylpiperidine and 2,2-barylmorpholine derivatives | |
DK1068238T3 (en) | INTEGRITY UNIT RODIMES AND SUBUNIT THEREOF | |
DK0903130T3 (en) | Improvements in ostomy devices | |
DE69916694D1 (en) | 2-hydroxy-5-methyl-hexan-3-one and 3-hydroxy-5-methyl-hexan-2-one | |
PT811593E (en) | INSECTICID AND ACARICID AGENTS 1,4-DIARY-2-FLUOR-2-BUTENE | |
DK1140952T3 (en) | Phosphorus-organic compounds and their use | |
NO983556D0 (en) | Formulation and application | |
DE29722200U1 (en) | Size and shape-changeable garment | |
NO981089D0 (en) | Epoxy-azetidinones, preparation and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |